Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice

European Journal of Nutrition

Volumn 55, Issue 3, 2016, Pages 1153-1164

  Kanuri, Giridhar ^a   Landmann, Marianne ^a   Priebs, Josephine ^a   Spruss, Astrid ^b   Löscher, Marina ^b   Ziegenhardt, Doreen ^a   Röhl, Carolin ^b   Degen, Christian ^a   Bergheim, Ina ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Adiponectin; Ethanol; PAI 1; SIRT1; Visceral fat

Indexed keywords

4 METHYLPYRAZOLE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CASPASE 9; DRINKING WATER; FATTY ACID; GLUCOKINASE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PERILIPIN; PERILIPIN 2; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TAP WATER; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER; ADIPOQ PROTEIN, MOUSE; CASP9 PROTEIN, MOUSE; SIRT1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; IN VITRO STUDY; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NEUTROPHIL COUNT; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; 3T3 CELL LINE; ANIMAL; BLOOD; CELL LINE; DRINKING BEHAVIOR; LIPID METABOLISM; LIVER; METABOLISM; MOUSE MUTANT; NON-ALCOHOLIC FATTY LIVER DISEASE; SIGNAL TRANSDUCTION;

3T3 CELLS; ADIPONECTIN; ALCOHOL DRINKING; ANIMALS; BODY WEIGHT; CASPASE 9; CELL LINE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ETHANOL; FATTY ACIDS, NONESTERIFIED; INSULIN; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIVER; MALE; MICE; MICE, OBESE; NON-ALCOHOLIC FATTY LIVER DISEASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIGNAL TRANSDUCTION; SIRTUIN 1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929646229     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0929-7     Document Type: Article

References (55)

1. Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121
2. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44–52
3. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI (2006) Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 21:138–143
4. Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836–1846
5. Lelbach WK (1975) Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 252:85–105
6. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB (2012) Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 57:384–391
7. Moriya A, Iwasaki Y, Ohguchi S, Kayashima E, Mitsumune T, Taniguchi H, Ikeda F, Shiratori Y, Yamamoto K (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33:378–388
8. White IR, Altmann DR, Nanchahal K (2002) Alcohol consumption and mortality: modelling risks for men and women at different ages. BMJ 325:191
9. Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572–1585
10. Fromenty B, Vadrot N, Massart J, Turlin B, Barri-Ova N, Letteron P, Fautrel A, Robin MA (2009) Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice. J Pharmacol Exp Ther 331:23–34
11. Wang Y, Seitz HK, Wang XD (2010) Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 34:567–573
12. You M, Considine RV, Leone TC, Kelly DP, Crabb DW (2005) Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42:568–577
13. Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR (2013) Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis. J Nutr Biochem 24:1436–1445
14. Xu J, Lai KK, Verlinsky A, Lugea A, French SW, Cooper MP, Ji C, Tsukamoto H (2011) Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 55:673–682
15. Assuncao M, Santos-Marques MJ, Monteiro R, Azevedo I, Andrade JP, Carvalho F, Martins MJ (2009) Red wine protects against ethanol-induced oxidative stress in rat liver. J Agric Food Chem 57:6066–6073
16. Chiva-Blanch G, Urpi-Sarda M, Ros E, Valderas-Martinez P, Casas R, Arranz S, Guillen M, Lamuela-Raventos RM, Llorach R, Andres-Lacueva C, Estruch R (2013) Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. Clin Nutr 32:200–206
17. Gronbaek M, Jensen MK, Johansen D, Sorensen TI, Becker U (2004) Intake of beer, wine and spirits and risk of heavy drinking and alcoholic cirrhosis. Biol Res 37:195–200
18. Konrat C, Mennen LI, Caces E, Lepinay P, Rakotozafy F, Forhan A, Balkau B (2002) Alcohol intake and fasting insulin in French men and women. The D.E.S.I.R study. Diabetes Metab 28:116–123
19. Rodriguez FD, Simonsson P, Alling C (1992) A method for maintaining constant ethanol concentrations in cell culture media. Alcohol Alcohol 27:309–313
20. Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, Bergheim I (2009) Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J Nutr 139:482–487
21. Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321
22. Spruss A, Henkel J, Kanuri G, Blank D, Puschel GP, Bischoff SC, Bergheim I (2012) Female mice are more susceptible to non-alcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase—plasminogen activator inhibitor 1-cascade but not the hepatic endotoxin response. Mol Med 18:1346–1355
23. Orlicky DJ, Roede JR, Bales E, Greenwood C, Greenberg A, Petersen D, McManaman JL (2011) Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties. Alcohol Clin Exp Res 35:1020–1033
24. Qiao L, Shao J (2006) SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 281:39915–39924
25. Blomstrand R, Theorell H (1970) Inhibitory effect on ethanol oxidation in man after administration of 4-methylpyrazole. Life Sci II 9:631–640
26. Wu JC, Merlino G, Fausto N (1994) Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci USA 91:674–678
27. Cleophas TJ (1999) Wine, beer and spirits and the risk of myocardial infarction: a systematic review. Biomed Pharmacother 53:417–423
28. Nova E, Baccan GC, Veses A, Zapatera B, Marcos A (2012) Potential health benefits of moderate alcohol consumption: current perspectives in research. Proc Nutr Soc 71:307–315
29. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, Parry CD, Patra J, Popova S, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B (2010) The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 105:817–843
30. Hidestrand M, Shankar K, Ronis MJ, Badger TM (2005) Effects of light and dark beer on hepatic cytochrome P-450 expression in male rats receiving alcoholic beverages as part of total enteral nutrition. Alcohol Clin Exp Res 29:888–895
31. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA (2011) Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 342:d636
32. Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51:212–223
33. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871
34. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519–1523
35. Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33:191–205
36. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, Johnson RS, Kahn CR (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190
37. Gonzalez-Rodriguez A, Mas Gutierrez JA, Sanz-Gonzalez S, Ros M, Burks DJ, Valverde AM (2010) Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 59:588–599
38. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880–1889
39. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904
40. Bonnet F, Disse E, Laville M, Mari A, Hojlund K, Anderwald CH, Piatti P, Balkau B (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228–3237
41. Cintra DE, Pauli JR, Araujo EP, Moraes JC, de Souza CT, Milanski M, Morari J, Gambero A, Saad MJ, Velloso LA (2008) Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 48:628–637
42. Qin B, Anderson RA, Adeli K (2008) Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Am J Physiol Gastrointest Liver Physiol 294:G1120–G1129
43. Cheng Z, White MF (2011) Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 14:649–661
44. Satoh T (2014) Rho GTPases in insulin-stimulated glucose uptake. Small GTPases 5:e28102
45. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100
46. Ji L, Zhang X, Liu W, Huang Q, Yang W, Fu F, Ma H, Su H, Wang H, Wang J, Zhang H, Gao F (2013) AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury. PLoS ONE 8:e69910
47. Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Maulik G, Bagchi M, Bagchi D, Maulik N (2009) Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim Biophys Acta 1792:39–48
48. Adachi M, Brenner DA (2008) High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology 47:677–685
49. Yano W, Kubota N, Itoh S, Kubota T, Awazawa M, Moroi M, Sugi K, Takamoto I, Ogata H, Tokuyama K, Noda T, Terauchi Y, Ueki K, Kadowaki T (2008) Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. Endocr J 55:515–522
50. Nascimento AF, Ip BC, Luvizotto RA, Seitz HK, Wang XD (2013) Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats. Hepatobiliary Surg Nutr 2:252–259
51. Liang X, Hu M, Rogers CQ, Shen Z, You M (2011) Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxid Redox Signal 15:425–435
52. Mandal P, Roychowdhury S, Park PH, Pratt BT, Roger T, Nagy LE (2010) Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. J Immunol 185:4928–4937
53. DeCarli LM, Lieber CS (1967) Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet. J Nutr 91:331–336
54. Campfield LA, Smith FJ, Burn P (1996) The OB protein (leptin) pathway–a link between adipose tissue mass and central neural networks. Horm Metab Res 28:619–632
55. Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697–10703